Quinuclidine carbonate salts and medicinal composition thereof
申请人:Chiesi Farmaceutici S.p.A.
公开号:US08039483B2
公开(公告)日:2011-10-18
Quinuclidine carbonate derivatives act as muscarinic receptor antagonists and are effective for the prevention and/or treatment of a broncho-obstructive or inflammatory diseases.
QUINUCLIDINE CARBONATE DERIVATIVES AND MEDICINAL COMPOSITION THEREOF
申请人:CHIESI FARMACEUTICI S.p.A.
公开号:EP2313404B1
公开(公告)日:2012-03-28
US8039483B2
申请人:——
公开号:US8039483B2
公开(公告)日:2011-10-18
[EN] QUINUCLIDINE CARBONATE DERIVATIVES AND MEDICINAL COMPOSITION THEREOF<br/>[FR] DÉRIVÉS DE CARBONATE DE QUINUCLIDINE ET COMPOSITION MÉDICINALE LES COMPRENANT
申请人:CHIESI FARMA SPA
公开号:WO2010015324A1
公开(公告)日:2010-02-11
The invention relates to quinuclidine carbonate derivatives acting as muscarinic receptor antagonists, to methods of preparing such derivatives, to compositions comprising them and therapeutic use thereof.